Product Information
SEVELAMER HCL 800 MG TABLET is a generic product labeled by Sanofi-Aventis U.S. LLC, priced at $0.7735 per EA under NDC 00955104818. Its NADAC has been published 323 times since Mar 18, 2020.
FDA first approved this application on Jul 12, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Sevelamer Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
800 mg/1
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00955104818
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
SEVELAMER HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021179FDA Approved
7/12/2000
TE Code
AB
On Market Since
2/13/2019
Pharmacological Classes
Price Statistics
The NADAC for SEVELAMER HCL 800 MG TABLET has been published 323 times since Mar 18, 2020, and over the history we have for it it has declined 83.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7735 per EA |
|---|---|
| All-time high | $5.0305 (Mar 10, 2021) |
| All-time low | $0.7735 (May 20, 2026) |
| 52-week high | $1.3679 |
| 52-week low | $0.7735 |
| Median price | $2.6587 |
| Average price | $2.9085 |
| Largest weekly change | -37.7% (May 22, 2024) |
| Weeks tracked | 323 |
| Tracking since | Mar 18, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
-18.3%
1Y
-43.5%
3Y
-63.5%
5Y
-83.8%
All
-83.3%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SEVELAMER HCL 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SEVELAMER HCL 800 MG TABLET, manufactured by Sanofi-Aventis U.S. LLC, is $0.7735 per EA (NDC 00955104818), effective May 20, 2026.
How has the price of SEVELAMER HCL 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for SEVELAMER HCL 800 MG TABLET has declined 83.3%. It has been tracked across 323 weekly CMS publications since Mar 18, 2020.
What are the highest and lowest recorded NADAC prices for SEVELAMER HCL 800 MG TABLET?
Since Mar 18, 2020, the NADAC for SEVELAMER HCL 800 MG TABLET has ranged from a low of $0.7735 (May 20, 2026) to a high of $5.0305 (Mar 10, 2021), with a median of $2.6587 per EA.
Are there cheaper alternatives to SEVELAMER HCL 800 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SEVELAMER HCL 800 MG TABLET, is $0.7025 per EA — about 9% below SEVELAMER HCL 800 MG TABLET.
Who manufactures SEVELAMER HCL 800 MG TABLET?
SEVELAMER HCL 800 MG TABLET (NDC 00955104818) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a generic product.